News and Insights
Medicare Drug Price Negotiations and Anticipated Ripple Effects …
Pancreatic Cancer Screening, the New Guidelines, and Barriers to Care …
Evolent has more than 1,400 clinicians—including 300 physicians—focused on improving health outcomes for cancer, cardiovascular disease, musculoskeletal conditions and more. Watch to learn how our evidence-driven, patient-first model helps produce more …
It's Cancer Prevention Month. Here are 11 ways to reduce your risk. …
Generative AI can likely help devise and update high-value pathways, but it’s not going to replace expert consensus anytime soon. Like many of my colleagues, I’m bullish on the use of artificial intelligence to transform specialty care management for the …
Von Nguyen brings a background in value-based payment models, artificial intelligence and health plan operations to the challenges of high-value specialty care. Dr. Von Nguyen has spent his career paving the way for better outcomes and affordability in …
To reduce the fragmentation of care for complex conditions, we need to take on the fee-for-service models that contribute to it, says Evolent's Dr. Vishnukamal Golla. Seamless coordination between primary and specialty providers is vital to achieving …
Another Toxicity of Cancer Treatment …
Dr. Sadie Dobrozsi Discusses the Future of Genetic Testing in Oncology and the Impact on Women’s Health …
How can payers address skyrocketing costs for the care of complex health conditions? Members with complex conditions continue to experience uneven quality and health outcomes that disproportionately impact trends in health care spending, despite the …